Table 3.
Antibacterial effects.
|
|
|
|
MIC[g] [μg/mL] |
|||||
|---|---|---|---|---|---|---|---|---|
|
|
TEI |
VAN |
12 |
13 |
15 |
16 |
17 |
18 |
|
Bacillus subtilis ATCC[a] 6633 |
0.5 |
0.5 |
32 |
16 |
0.5 |
2 |
128 |
4 |
|
Staphylococcus aureus MSSA[b] ATCC 29213 |
0.5 |
0.5 |
4 |
8 |
0.5 |
0.5 |
16 |
8 |
|
S. aureus MRSA[c] ATCC 33591 |
0.5 |
0.5 |
8 |
8 |
0.5 |
0.5 |
16 |
4 |
|
Staphylococcus epidermidis ATCC 35984 biofilm |
2 |
2 |
8 |
16 |
0.5 |
0.5 |
16 |
4 |
|
S. epidermidis mecA[d] |
16 |
4 |
8 |
8 |
0.5 |
0.5 |
256 |
8 |
|
Enterococcus faecalis ATCC 29212 |
2 |
1 |
8 |
4 |
0.5 |
1 |
256 |
16 |
|
E. faecalis 15376 VanA[e] |
256 |
256 |
16 |
256 |
1 |
2 |
256 |
32 |
|
E. faecalis ATCC 51299 VanB[f] |
4 |
128 |
16 |
32 |
4 |
1 |
256 |
32 |
[a] American Type Culture Collection. [b] Methicillin‐sensitive S. aureus. [c] Methicillin‐resistant S. aureus. [d] mecA gene expression in Staphylococcus. [e] vanA gene positive. [f] vanB gene positive. [g] Minimum inhibitory concentration. TEI: teicoplanin, VAN: vancomycin.